Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06098144 · ClinicalTrials.gov registry record · Phase 4
Smoking Cessation Program in the Construction Sector
A Phase 4 study of Smoking Cessation and Tobacco Smoking, sponsored by University of Miami.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 608
- Enrollment target
- 1
- Study location
NCT06098144 is a Phase 4 study of Smoking Cessation and Tobacco Smoking that is actively recruiting participants, run by University of Miami. The registered enrollment target is 608 participants, above the 471-participant average among 188 other Smoking Cessation trials with a reported enrollment target (29% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06098144, a Phase 4 study of Smoking Cessation and Tobacco Smoking, is actively recruiting participants, sponsored by University of Miami.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 608 participants
- Enrollment target
- 1
- Study location
Study Summary
The main objective of this study is to identify the optimal adaptive smoking cessation program for the construction sector in terms of effectiveness, cost-effectiveness, and potential implementation.
Conditions Studied
Interventions
- DRUG Nicorette
- BEHAVIORAL Tobacco Quit-line
- BEHAVIORAL Brief Behavioral Counseling
- BEHAVIORAL Intensive Behavioral Counseling
Study Locations (1)
Florida
- Don Soffer Clinical Research Center - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 608 participants |
| Start Date | 2024-04-10 |
| Est. Completion | 2027-02-28 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06098144
The ClinicalTrials.gov registry entry for NCT06098144 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 608 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 471-participant average among 188 other Smoking Cessation trials with a reported enrollment target (29% higher). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Smoking Cessation appearing as the primary indexed condition, and to 4 interventions - of which Nicorette is the first listed.
NCT06098144 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT06098144 about?
NCT06098144 is a clinical study titled "Smoking Cessation Program in the Construction Sector". The main objective of this study is to identify the optimal adaptive smoking cessation program for the construction sector in terms of effectiveness, cost-effectiveness, and potential implementation.
What is the current status of trial NCT06098144?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 608 participants. The study started on 2024-04-10. Estimated completion is 2027-02-28.
What conditions does trial NCT06098144 study?
This clinical trial studies the following conditions: Smoking Cessation, Tobacco Smoking, Tobacco Use Cessation.
What interventions are being tested in trial NCT06098144?
The interventions under investigation include: Nicorette (DRUG), Tobacco Quit-line (BEHAVIORAL), Brief Behavioral Counseling (BEHAVIORAL), Intensive Behavioral Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT06098144?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06098144 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children
RECRUITING · Phase 4
-
The Options 2 Study
RECRUITING · Phase 4
-
The Avenues Study: Dual Use Cessation
RECRUITING · Phase 4
-
Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care
RECRUITING · Phase 4
-
Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites
ACTIVE NOT RECRUITING · Phase 4
-
Informing Tobacco Treatment Guidelines for African American Non-Daily Smokers
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.